Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
TCRX on Nasdaq
Lynx1 Capital Management LP - trading volume in the past year for TScan Therapeutics, Inc.
Holdings reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Pre-funded Warrant (right to buy) |
7,500,000 |
$30,000,000 |
$4.00 |
26 Dec 2024 |
Indirect |
Common Stock |
|
| Common Stock |
8,019,148 |
$7,208,412 |
$0.8989 |
23 Dec 2025 |
Indirect |
|
|
Transactions reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.